167 related articles for article (PubMed ID: 32604732)
61. State-Targeting Stabilization of Adenosine A
Mitsumoto M; Sugaya K; Kazama K; Nakano R; Kosugi T; Murata T; Koga N
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884716
[TBL] [Abstract][Full Text] [Related]
62. Modulation of innate immunity by adenosine receptor stimulation.
Ramakers BP; Riksen NP; van der Hoeven JG; Smits P; Pickkers P
Shock; 2011 Sep; 36(3):208-15. PubMed ID: 21617576
[TBL] [Abstract][Full Text] [Related]
63. Targeting A3 and A2A adenosine receptors in the fight against cancer.
Merighi S; Battistello E; Giacomelli L; Varani K; Vincenzi F; Borea PA; Gessi S
Expert Opin Ther Targets; 2019 Aug; 23(8):669-678. PubMed ID: 31189400
[No Abstract] [Full Text] [Related]
64. Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.
Price LA; Strnad J; Pausch MH; Hadcock JR
Mol Pharmacol; 1996 Oct; 50(4):829-37. PubMed ID: 8863827
[TBL] [Abstract][Full Text] [Related]
65. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
66. Adenosine A2A receptor signaling attenuates LPS-induced pro-inflammatory cytokine formation of mouse macrophages by inducing the expression of DUSP1.
Köröskényi K; Kiss B; Szondy Z
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1461-71. PubMed ID: 27066978
[TBL] [Abstract][Full Text] [Related]
67. Adenosine A
Lanznaster D; Massari CM; Marková V; Šimková T; Duroux R; Jacobson KA; Fernández-Dueñas V; Tasca CI; Ciruela F
Cells; 2019 Dec; 8(12):. PubMed ID: 31847113
[TBL] [Abstract][Full Text] [Related]
68. Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.
Li S; Geiger NH; Soliman ML; Hui L; Geiger JD; Chen X
J Alzheimers Dis; 2015; 47(1):73-83. PubMed ID: 26402756
[TBL] [Abstract][Full Text] [Related]
69. Efficient G protein coupling is not required for agonist-mediated internalization and membrane reorganization of the adenosine A
Stoddart LA; Kilpatrick LE; Corriden R; Kellam B; Briddon SJ; Hill SJ
FASEB J; 2021 Apr; 35(4):e21211. PubMed ID: 33710641
[TBL] [Abstract][Full Text] [Related]
70. Adenosine A2A receptor is involved in cell surface expression of A2B receptor.
Moriyama K; Sitkovsky MV
J Biol Chem; 2010 Dec; 285(50):39271-88. PubMed ID: 20926384
[TBL] [Abstract][Full Text] [Related]
71. [18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents.
Haeusler D; Kuntner C; Nics L; Savli M; Zeilinger M; Wanek T; Karagiannis P; Lanzenberger RR; Langer O; Shanab K; Spreitzer H; Wadsak W; Hacker M; Mitterhauser M
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):741-9. PubMed ID: 25601336
[TBL] [Abstract][Full Text] [Related]
72. Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma.
Schlötzer-Schrehardt U; Zenkel M; Decking U; Haubs D; Kruse FE; Jünemann A; Coca-Prados M; Naumann GO
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2023-34. PubMed ID: 15914619
[TBL] [Abstract][Full Text] [Related]
73. Down-regulation of the A3 adenosine receptor in human mast cells upregulates mediators of angiogenesis and remodeling.
Rudich N; Dekel O; Sagi-Eisenberg R
Mol Immunol; 2015 May; 65(1):25-33. PubMed ID: 25597247
[TBL] [Abstract][Full Text] [Related]
74. A2A adenosine receptor protects tumors from antitumor T cells.
Ohta A; Gorelik E; Prasad SJ; Ronchese F; Lukashev D; Wong MK; Huang X; Caldwell S; Liu K; Smith P; Chen JF; Jackson EK; Apasov S; Abrams S; Sitkovsky M
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13132-7. PubMed ID: 16916931
[TBL] [Abstract][Full Text] [Related]
75. Characterization of binding kinetics of A
Koretz KS; McGraw CE; Stradley S; Elbaradei A; Malmstadt N; Robinson AS
Biophys J; 2021 May; 120(9):1641-1649. PubMed ID: 33675761
[TBL] [Abstract][Full Text] [Related]
76. Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice.
Belikoff B; Hatfield S; Sitkovsky M; Remick DG
Shock; 2011 Apr; 35(4):382-7. PubMed ID: 21192284
[TBL] [Abstract][Full Text] [Related]
77. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
[TBL] [Abstract][Full Text] [Related]
78. Dynamic behavior of the active and inactive states of the adenosine A(2A) receptor.
Lee S; Bhattacharya S; Grisshammer R; Tate C; Vaidehi N
J Phys Chem B; 2014 Mar; 118(12):3355-65. PubMed ID: 24579769
[TBL] [Abstract][Full Text] [Related]
79. Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway.
Choukèr A; Thiel M; Lukashev D; Ward JM; Kaufmann I; Apasov S; Sitkovsky MV; Ohta A
Mol Med; 2008; 14(3-4):116-23. PubMed ID: 18163162
[TBL] [Abstract][Full Text] [Related]
80. Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells.
Masoumi E; Jafarzadeh L; Mirzaei HR; Alishah K; Fallah-Mehrjardi K; Rostamian H; Khakpoor-Koosheh M; Meshkani R; Noorbakhsh F; Hadjati J
J Exp Clin Cancer Res; 2020 Mar; 39(1):49. PubMed ID: 32151275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
